These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17568867)

  • 21. Azithromycin Is Equally Effective as Amoxicillin in Children with Solitary Erythema Migrans.
    Arnež M; Ružić-Sabljić E
    Pediatr Infect Dis J; 2015 Oct; 34(10):1045-8. PubMed ID: 26186104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
    Langley JM; Halperin SA; Boucher FD; Smith B;
    Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
    Biebuyck XA
    J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.
    Brusse-Keizer M; VanderValk P; van der Zanden RW; Nijdam L; van der Palen J; Hendrix R; Movig K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():455-61. PubMed ID: 25767383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
    Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
    Gris P
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
    Guven M; Bulut Y; Sezer T; Aladag I; Eyibilen A; Etikan I
    Int J Pediatr Otorhinolaryngol; 2006 May; 70(5):915-23. PubMed ID: 16293317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study.
    Quach C; Collet JP; LeLorier J
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):163-70. PubMed ID: 15386697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
    Canut A; Martín-Herrero JE; Labora A; Maortua H
    J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An observational cohort study of Chlamydia trachomatis treatment in pregnancy.
    Rahangdale L; Guerry S; Bauer HM; Packel L; Rhew M; Baxter R; Chow J; Bolan G
    Sex Transm Dis; 2006 Feb; 33(2):106-10. PubMed ID: 16432482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
    Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
    J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin.
    Patel H; Calip GS; DiDomenico RJ; Schumock GT; Suda KJ; Lee TA
    JAMA Netw Open; 2020 Sep; 3(9):e2016864. PubMed ID: 32930780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation].
    Faber M; Jahnz-Rózyk K; Targowski T; Mamełka B
    Pol Merkur Lekarski; 2003 Jan; 14(79):36-8. PubMed ID: 12712826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
    MMW Fortschr Med; 2004 Mar; 146(11):56. PubMed ID: 15152775
    [No Abstract]   [Full Text] [Related]  

  • 38. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials.
    Pitsouni E; Iavazzo C; Athanasiou S; Falagas ME
    Int J Antimicrob Agents; 2007 Sep; 30(3):213-21. PubMed ID: 17596917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
    Paris R; Confalonieri M; Dal Negro R; Ligia GP; Mos L; Todisco T; Rastelli V; Perna G; Cepparulo M
    J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation of chronic obstructive pulmonary disease: a role of antibiotics?
    Rapić M
    Coll Antropol; 2014 Dec; 38 Suppl 2():223-6. PubMed ID: 25643555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.